These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 3484707
1. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry. Schneider JS, Yuwiler A, Markham CH. Exp Neurol; 1986 Feb; 91(2):293-307. PubMed ID: 3484707 [Abstract] [Full Text] [Related]
2. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain. Schneider JS, Denaro FJ. J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510 [Abstract] [Full Text] [Related]
3. Parkinsonism induced with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cats: behavioral, biochemical and pathological studies. Chen S, Zhou X, Xu D, Tang Q, Xu X. Chin Med Sci J; 1993 Dec; 8(4):223-6. PubMed ID: 8032069 [Abstract] [Full Text] [Related]
5. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR. Neurosci Lett; 1985 Oct 24; 61(1-2):195-200. PubMed ID: 3878482 [Abstract] [Full Text] [Related]
9. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction]. Nishi K, Kondo T, Narabayashi H. No To Shinkei; 1987 Jul 24; 39(7):663-72. PubMed ID: 3314916 [Abstract] [Full Text] [Related]
10. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate. Porrino LJ, Burns RS, Crane AM, Palombo E, Kopin IJ, Sokoloff L. Life Sci; 1987 Apr 27; 40(17):1657-64. PubMed ID: 3494179 [Abstract] [Full Text] [Related]
12. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease]. Lange KW. Fortschr Neurol Psychiatr; 1989 Apr 27; 57(4):142-8. PubMed ID: 2656447 [Abstract] [Full Text] [Related]
13. Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease? Allen JM, Cross AJ, Yeats JC, Ghatei MA, McGregor GP, Close SP, Pay S, Marriott AS, Tyers MB, Crow TJ. Brain; 1986 Feb 27; 109 ( Pt 1)():143-57. PubMed ID: 2417654 [Abstract] [Full Text] [Related]
14. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment. Schneider JS. J Neurosci Res; 1992 Jan 27; 31(1):112-9. PubMed ID: 1613817 [Abstract] [Full Text] [Related]
15. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Elsworth JD, Taylor JR, Sladek JR, Collier TJ, Redmond DE, Roth RH. Neuroscience; 2000 Jan 27; 95(2):399-408. PubMed ID: 10658619 [Abstract] [Full Text] [Related]
19. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH. Brain Res; 1996 Nov 25; 741(1-2):185-96. PubMed ID: 9001722 [Abstract] [Full Text] [Related]
20. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ. Life Sci; 1985 Jan 21; 36(3):213-8. PubMed ID: 3871241 [Abstract] [Full Text] [Related] Page: [Next] [New Search]